Fast Titration in the Treatment of Schizophrenia, Taiwan
|ClinicalTrials.gov Identifier: NCT00304473|
Recruitment Status : Completed
First Posted : March 20, 2006
Last Update Posted : March 25, 2009
Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Drug: Quetiapine fumarate||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial|
|Study Start Date :||August 2004|
|Actual Study Completion Date :||April 2006|
- Compare the safety and tolerability of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
- Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00304473
|Study Director:||AstraZeneca Taiwan Medical Director, MD||AstraZeneca|